Back to search

Small-cell lung cancer: Patients included in clinical trials are not representative of the patient population as a whole

Data up to Jan 2025

Published1999
Citations79
References33

Total Citations Per Year

Abstract

References (33)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Information and Participation Preferences Among Cancer Patients

1980 • 1,144 citations

A New Design for Randomized Clinical Trials

1979 • 1,027 citations

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1993 • 547 citations

Physicians’ Reasons for Not Entering Eligible Patients in a Randomized Clinical Trial of Surgery for Breast Cancer

1984 • 408 citations

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

1990 • 385 citations

Cancer in the elderly: why so badly treated?

1990 • 351 citations

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1989 • 230 citations

Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation

1987 • 218 citations

An overview of prognostic factors in small cell lung cancer

1990 • 206 citations

Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer.

1986 • 206 citations

Selection bias in clinical trials.

1985 • 145 citations

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1991 • 143 citations

Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland.

1989 • 129 citations

Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy.

1981 • 114 citations

Cancer Treatment Protocols

1988 • 79 citations

Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis

1990 • 68 citations

Cancer patient accessions into clinical trials A pilot investigation into some patient and physician determinants of entry

1982 • 63 citations

Accrual of radiotherapy patients to clinical trials

1983 • 52 citations

Consent as a Barrier to Research

1979 • 42 citations

Management of small cell lung cancer

2002 • 42 citations

Prognosis at presentation of small cell carcinoma of the lung

1990 • 39 citations

Sick population ? treated population: the need for a better definition

1991 • 26 citations

Staging of the patient with small cell lung cancer.

1997 • 25 citations

Treatment of small-cell lung cancer on protocol: potential bias of results.

1986 • 24 citations

MANAGEMENT OF SMALL-CELL LUNG CANCER

1993 • 17 citations

Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC)☆

1990 • 16 citations

Pretreatment Staging Evaluation in Small Cell Lung Carcinoma

1992 • 13 citations

Evaluation of the informed consent procedure in cancer patients candidate to immunotherapy

1995 • 12 citations

Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy

1993 • 6 citations

Age as a criterion for eligibility in a lung cancer clinical trial

1982 • 5 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Small-cell lung cancer: Patients included in clinical trials are not representative of… (1999) – Annals of Oncology | Metascience Observatory Explorer